26 results
management treatment infections opportunistic prevention medications diagnosis tuberculosis antibiotics cardiology comparison dosing mycobacterium nephrology anaphylaxis anesthesia anesthesiology antiarrhythmic antibiogram antifungals
Clinical Pharmacologic Properties of Antiarrhythmic Drugs #Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Antiarrhythmic Drugs ... Antiarrhythmic #Drugs ... #Medications #Pharmacology ... #Cardiology #Table
Doses of Antituberculosis Drugs for Adults and Children - IDSA First-line drugs: • Isoniazid • Rifampin •
Antituberculosis Drugs ... and Children - IDSA ... First-line drugs ... Medications #management #pharmacology ... #Table
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... chew, or crush tablet ... suspension 4–6 mL ... opportunistic #infections #HIVAIDS ... #pharmacology
Vasopressors Table Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Dobutamine 2-20 mcg ... Internet Book of Critical ... Vasopressors #Properties #Table ... #Pharmacology #
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
Back to the "10 Need to Know" series - Drug Therapeutic Target Levels. For lithium, target
Know" series - Drug ... (0.5 - 0.8 ng/mL ... Ranges #Toxicology #Pharmacology ... #Diagnosis #Table
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB) •
IDSA - Clinical ... Regimen for Multi-Drug ... antimicrobials #regimens #pharmacology ... #dosing #idsa # ... drugs #steps
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
IDSA Recommendations ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
IDSA Recommendations ... HIV-AIDS Preventing Clinical ... Trypanosomiasis #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
Summary of Diuretic Agents Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction CARBONIC ANHYDRASE
Agents Subclass, Drug ... Action, Effects, Clinical ... #Medications #Pharmacology ... #summary #table
No results found for "MCL pharmacology table clinical drugs idsa hivaids"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MCL #pharmacology #table #clinical #drugs #idsa #hivaids